Sarah Cannon-Minnie Pearl Cancer Center
Nashville, Tennessee, United States
Cancer treatment center in Nashville, Tennessee
2300 Patterson St, Nashville, TN 37203
About Sarah Cannon-Minnie Pearl Cancer Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Alliance for Clinical Trials in Oncology
1
Case Comprehensive Cancer Center
1
Daiichi Sankyo, Inc.
1
Genzyme, a Sanofi Company
1
Ligand Pharmaceuticals
1
NCIC Clinical Trials Group
1
National Cancer Institute (NCI)
1
Pfizer
1
Vanderbilt-Ingram Cancer Center
1
Clinical Trials at Sarah Cannon-Minnie Pearl Cancer Center
During the past decade, Sarah Cannon-Minnie Pearl Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Paclitaxel Plus Radiation Therapy in Treating Patients With Untreated Stage III Non-small Cell Lung Cancer
1997-01-01
2000-01-01
Completed
6
Bexarotene in Treating Patients With Metastatic Breast Cancer
1998-10-01
2003-03-01
Completed
180
Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer
1999-04-01
2011-07-01
Completed
4,590
Topotecan in Treating Patients With Relapsed Small Cell Lung Cancer
1999-03-01
2001-11-01
Completed
4
Monoclonal Antibody Plus Chemotherapy in Treating Patients With Advanced Colorectal Cancer That Overexpresses HER2
1999-09-01
Completed
32
Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer
1999-10-01
2001-09-01
Completed
ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment
1999-05-01
Withdrawn
0
Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
2001-07-01
2005-04-01
Completed
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Sarah Cannon-Minnie Pearl Cancer Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 1 trials, followed by "Case Comprehensive Cancer Center" with 1 trials
sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored, "Genzyme, a Sanofi Company" with 1 trials sponsored and "Ligand Pharmaceuticals"
with 1 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Sarah Cannon-Minnie Pearl Cancer Center"
#1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator and "Smith Kline Beecham" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Sarah Cannon-Minnie Pearl Cancer Center
According to Clinical.Site data, the most researched conditions in "Sarah Cannon-Minnie Pearl Cancer Center" are
"Pancreatic Cancer" (3 trials), "Breast Cancer" (2 trials), "Lung Cancer" (2 trials), "Colorectal Cancer" (1 trials) and "Fallopian Tube Cancer" (1 trials). Many other conditions were trialed in "Sarah Cannon-Minnie Pearl Cancer Center" in a lesser frequency.
Clinical Trials Intervention Types at Sarah Cannon-Minnie Pearl Cancer Center
Most popular intervention types in "Sarah Cannon-Minnie Pearl Cancer Center" are "Drug" (8 trials), "Radiation" (2 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "gemcitabine hydrochloride" (3 trials), "ILX-295501" (1 trials), "bexarotene" (1 trials), "chemotherapy" (1 trials) and "erlotinib hydrochloride" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Sarah Cannon-Minnie Pearl Cancer Center
The vast majority of trials in "Sarah Cannon-Minnie Pearl Cancer Center" are
7 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Sarah Cannon-Minnie Pearl Cancer Center
Currently, there are NaN active trials in "Sarah Cannon-Minnie Pearl Cancer Center".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Sarah Cannon-Minnie Pearl Cancer Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Sarah Cannon-Minnie Pearl Cancer Center, 1 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".